2025-10-03 - Analysis Report
Okay, here's a report summarizing the provided data for Albemarle Corp (ALB), along with analysis:

## Albemarle Corp (ALB) Analysis

**Ticker:** ALB
**Company Description:** Albemarle Corp is a specialty chemicals company with leading positions in lithium, bromine, and catalysts.

### 1. Performance vs. S&P 500 (VOO)

*   **ALB Cumulative Return:** -22.44%
*   **VOO Cumulative Return:** 97.56%
*   **Absolute Deviation:** -120.0

**Deviation Analysis:**

*   **Range:** The deviation between ALB and VOO has ranged from a maximum of 190.4 to a minimum of -120.5.
*   **Current Deviation:** The current deviation is -120.0, indicating significant underperformance compared to the S&P 500.
*   **Relative Deviation:** The relative deviation is 0.2, placing the current underperformance near the extreme low end of its historical range. This suggests the underperformance is near its worst relative to its past behavior.

**Alpha/Beta Analysis:**

| Year       | CAGR      | MDD      | Alpha    | Beta     | Cap(B) |
|------------|-----------|----------|----------|----------|--------|
| 2015-2017  | 85.0%     | 68.0%    | 56.0%    | 0.1      | 15.3   |
| 2016-2018  | 9.0%      | 68.0%    | -6.0%    | 0.0      | 9.2    |
| 2017-2019  | -44.0%    | 73.9%    | -66.0%   | 0.1      | 8.7    |
| 2018-2020  | 44.0%     | 79.4%    | 20.0%    | 0.2      | 17.6   |
| 2019-2021  | 149.0%    | 79.4%    | 103.0%   | -0.1     | 27.9   |
| 2020-2022  | 148.0%    | 79.9%    | 149.0%   | 0.5      | 25.9   |
| 2021-2023  | -26.0%    | 81.9%    | -27.0%   | 0.5      | 17.2   |
| 2022-2024  | -152.0%   | 81.9%    | -172.0%  | 0.3      | 10.3   |
| 2023-2025  | -244.0%   | 81.9%    | -306.0%  | -0.4     | 9.6    |

**Analysis:**

*   The table shows a highly variable performance over the analyzed periods.
*   **Alpha:**  Alpha is mostly negative in recent periods, meaning ALB is underperforming relative to its risk (Beta).  The period 2023-2025 shows significant underperformance.
*   **Beta:**  Beta values are generally low, suggesting ALB's price is not very sensitive to the market (S&P 500).  The negative Beta in 2019-2021 and 2023-2025 means it moved slightly opposite the market during those times.
*   **CAGR & MDD:**  The recent CAGR is very negative, with high Maximum Drawdown (MDD), indicating significant losses and volatility.
*   **Cap(B):** Market Cap has decreased from 27.9 billion to 9.6 billion, showing investors losing faith in the company.

### 2. Recent Price Action

*   **Current Price:** 80.47
*   **Last Market Data:** Price: 87.61, Previous Close: 84.47, Change: 3.72 (Indicates a significant positive change in the last session).
*   **5-day Moving Average:** 83.01
*   **20-day Moving Average:** 80.02
*   **60-day Moving Average:** 77.52

**Analysis:**

*   The recent price increase (3.72) indicates a potential short-term rebound.
*   The current price is above the 20-day and 60-day moving averages, which could be a short-term bullish signal.  However, it's below the 5-day moving average, suggesting some recent pullback.

### 3. Technical Indicators and Outlook

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended).  *Note: This seems contradictory given the other negative indicators.  Further investigation of the MRI calculation is warranted.*
*   **RSI:** 63.92 (Approaching overbought territory, but not yet extreme).
*   **PPO:** 0.37 (Positive, but not strongly indicative of a strong trend).
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (868 shares - Very Safe - MRI:0.90)
*   **Recent Relative Deviation Change (20-day):** 0.0 (Neutral).
*   **Expected Return (%):** 3624.7% (Significant outperformance vs. S&P 500 if investing for the long term (2+ years)).

**Analysis:**

*   The MRI suggests a high investment recommendation, but this is questionable given the other negative factors.
*   The recent price increase might continue, but the RSI indicates it's nearing overbought levels and could face resistance.
*   The very high expected return is an interesting point, suggesting that the model believes ALB is significantly undervalued for long-term investors.

### 4. Recent News & Significant Events

*   **[2025-10-02] Albemarle (ALB): Revisiting Valuation Following Recent Sector Swings (Simply Wall St.)** - Suggests market volatility is impacting Albemarle's valuation and a need to re-evaluate.
*   **[2025-10-01] Lithium Americas Spikes As U.S. Confirms Stake After MP Materials, Intel Investments (Investor's Business Daily)** - Positive news for the lithium sector, though not directly about Albemarle. Government investment in lithium production could indirectly benefit ALB.
*   **[2025-09-29] Albemarle (ALB) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)** - Highlights ALB's underperformance even when the overall market is doing well.
*   **[2025-09-25] Albemarle Corporation to Release Third Quarter 2025 Earnings Results on Wednesday, November 5, 2025 (PR Newswire)** - Upcoming earnings release will be a critical event for assessing the company's performance and future outlook.
*   **[2025-09-24] Why a U.S. Stake in Lithium Americas May Not Be a Good Deal for the Canadian Miner (Barrons.com)** - Raises questions about the long-term impact of government investments in lithium mining.

**Analysis:**

*   The news headlines present a mixed picture. While there's positive sentiment surrounding the lithium sector in general, there are concerns about Albemarle's valuation, underperformance, and the broader impact of government involvement in the industry. The upcoming earnings release will be crucial.

### 4-2. Analyst Opinions

*   **Consensus:** Hold (2.64)
*   **Target Price:** Average: 86.65, High: 200.00, Low: 58.00

**Analysis:**

*   The analyst consensus is "Hold," suggesting a neutral outlook on the stock.
*   The wide range in target prices (58.00 to 200.00) indicates significant uncertainty and differing opinions among analysts regarding ALB's future potential.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출      |
|------------|-------|-----------|
| 2025-08-04 | -0.16 | 1.33 B$   |
| 2025-04-30 | 0     | 1.08 B$   |
| 2024-11-06 | -9.45 | 1.35 B$   |
| 2024-07-31 | -1.96 | 1.43 B$   |
| 2025-08-04 | -1.96 | 1.43 B$   |

**Analysis:**

*   The recent EPS figures are concerning, with significant losses in several quarters.
*   While revenue has been relatively stable, the lack of profitability raises concerns about cost management and/or pricing pressures.
*   The duplicate entry for 2025-08-04 with different EPS and same Revenue requires clarification.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-06-30   | $1.33B     | 14.80%        |
| 2025-03-31   | $1.08B     | 14.51%        |
| 2024-12-31   | $1.23B     | 11.22%        |
| 2024-09-30   | $1.35B     | -7.68%        |
| 2024-06-30   | $1.43B     | -0.74%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE       |
|--------------|------------|-----------|
| 2025-06-30   | $10.24B    | 0.22%     |
| 2025-03-31   | $10.03B    | 0.41%     |
| 2024-12-31   | $9.96B     | 0.76%     |
| 2024-09-30   | $10.24B    | -10.44%   |
| 2024-06-30   | $11.22B    | -1.68%    |

**Analysis:**

*   **Profit Margin:** Profit margins have been volatile, with negative margins in some quarters.  The recent positive margins are encouraging, but need to be sustained.
*   **Equity:** Equity has decreased, which can be a sign of financial stress.
*   **ROE:**  Return on Equity has also been volatile, with negative ROE in some quarters. The recent low positive ROE values show lack of profitability.

### 7. Overall Summary and Conclusion

Albemarle Corp (ALB) presents a mixed investment picture.

**Key Concerns:**

*   **Significant Underperformance:** ALB has significantly underperformed the S&P 500, both recently and over the past several years.
*   **Negative Alpha:**  Recent negative alpha values indicate underperformance relative to its risk.
*   **Earnings Losses:**  Recent EPS figures have been negative, raising concerns about profitability.
*   **Volatile Financials:** Profit margins and ROE have been volatile, and Equity has decreased.
*   **Conflicting Signals:** The MRI gives a 'High Investment Recommended' signal while most other signals are negative, so needs further investigation.

**Potential Positives:**

*   **Recent Price Rebound:** Recent price movement and the 3.72 change in the last session suggests a potential short-term rebound.
*   **Lithium Sector Growth:** Overall positive sentiment surrounding the lithium sector could indirectly benefit ALB.
*   **High Expected Return (Long-Term):** The very high long-term expected return suggests the model believes ALB is currently undervalued.
*   **Positive Profit Margins:** Recent profit margins have been positive, suggesting a potential turnaround.

**Conclusion:**

ALB is a risky investment at this time. While there are potential positives, the significant underperformance, earnings losses, and volatile financials raise significant concerns.  The upcoming earnings release will be critical in determining the company's future direction.  Investors should exercise caution and carefully weigh the risks and potential rewards before investing in ALB.  The very high expected return should be viewed with skepticism until the company can demonstrate a consistent return to profitability and outperformance. The conflicting MRI also needs clarification.
